Catalyst Wire Dossier Catalyst Wire Dossier

ChimeriVax Dengue Tetravalent Vaccine

Chimeric tetravalent dengue vaccine · Sanofi Pasteur
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ChimeriVax Dengue Tetravalent Vaccine, covering 2018-02-27 to 2018-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects [Phase 2]

See pricing